-Reuters Citing Ukrainian Officials
Werewolf Therapeutics Said Updated Cash Guidance Provides Runway Through At Least Q1 Of 2025
Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (NASDAQ:HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to